Horizon Discovery plc Долг / собственный капитал
Что обозначает Долг / собственный капитал в Horizon Discovery plc?
Долг / собственный капитал Horizon Discovery Group plc является 0.22
Какое определение для Долг / собственный капитал?
Соотношение долга к собственному капиталу - это финансовое соотношение, показывающее относительную пропорцию собственного капитала и долга, используемых для финансирования активов компании.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Долг / собственный капитал компаний в Health Care сектор на LSE по сравнению с Horizon Discovery plc
Что делает Horizon Discovery plc?
Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.
Компании с долг / собственный капитал похож на Horizon Discovery plc
- Vectura Plc имеет Долг / собственный капитал из 0.22
- Kitex Garments имеет Долг / собственный капитал из 0.22
- Immuron имеет Долг / собственный капитал из 0.22
- JH Educational Technology INC имеет Долг / собственный капитал из 0.22
- Silver Viper Minerals имеет Долг / собственный капитал из 0.22
- Maxicity имеет Долг / собственный капитал из 0.22
- Horizon Discovery plc имеет Долг / собственный капитал из 0.22
- Bajaj Auto имеет Долг / собственный капитал из 0.22
- Graco имеет Долг / собственный капитал из 0.22
- Mi Ming Mart имеет Долг / собственный капитал из 0.22
- KuangChi Science имеет Долг / собственный капитал из 0.22
- Singular Health Ltd имеет Долг / собственный капитал из 0.22
- Strong Petrochemical имеет Долг / собственный капитал из 0.22